Jian Ding
Impact in
- Biotechnology top 5%
- Marine Sponges and Natural Products
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Alkaloids: synthesis and pharmacology 1
- Co-authors
- Min Huang (6 shared papers)Jin‐Jian Lu (2 shared papers)Liping Lin (6 shared papers)Meiyu Geng (6 shared papers)Yue‐Wei Guo (4 shared papers)Le‐Le Zhang (1 shared paper)Mu‐Yang Huang (1 shared paper)Jian‐Min Yue (3 shared papers)
In The Last Decade
Jian Ding
37 papers receiving 1.6k citations
Jian Ding's Hit Papers
Peers
Comparison fields: 5 of 69
- Drug Discovery 2
- Biotechnology 79
- Biomaterials 115
- Pharmacology 65
- Molecular Biology 278
Countries citing papers authored by Jian Ding
This map shows the geographic impact of Jian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Ding more than expected).
Fields of papers citing papers by Jian Ding
This network shows the impact of papers produced by Jian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Ding. The network helps show where Jian Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Jian Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Natural Products in Cancer Therapy: Past, Present and Future Hit paper breakdown → | 2021 | 517 |
| 2 | 2017 | 178 | |
| 3 | 2018 | 85 | |
| 4 | 2006 | 79 | |
| 5 | 2006 | 73 | |
| 6 | 2004 | 71 | |
| 7 | 2001 | 64 | |
| 8 | 2008 | 63 | |
| 9 | 2004 | 52 | |
| 10 | 2000 | 41 | |
| 11 | 2007 | 40 | |
| 12 | 2001 | 36 | |
| 13 | 2005 | 36 | |
| 14 | 2008 | 36 | |
| 15 | 2004 | 33 | |
| 16 | 2007 | 29 | |
| 17 | In vitro cytotoxicity of salvicine, a novel diterpenoid quinone. | 1999 | 28 |
| 18 | 2005 | 27 | |
| 19 | 2005 | 20 | |
| 20 | 2017 | 17 |
About Jian Ding
Jian Ding is a scholar working on Biomaterials, Pharmacology, Molecular Biology, Cancer Research and Discrete Mathematics and Combinatorics, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Bioactive Natural Diterpenoids Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Sesquiterpenes and Asteraceae Studies (2 papers), Alkaloids: synthesis and pharmacology (1 paper), Alzheimer's disease research and treatments (1 paper), Steroid Chemistry and Biochemistry (1 paper) and Carbohydrate Chemistry and Synthesis (1 paper). The work is most often cited by research in Drug Discovery (2 citations), Biotechnology (79 citations), Biomaterials (115 citations), Pharmacology (65 citations) and Molecular Biology (278 citations). Jian Ding has collaborated with scholars based in China, Macao and Hungary. Frequent co-authors include Min Huang, Jin‐Jian Lu, Liping Lin, Meiyu Geng, Yue‐Wei Guo, Le‐Le Zhang, Mu‐Yang Huang, Jian‐Min Yue, Qiaoshi Lian and Aiwei Bi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Natural Products, Biological and Pharmaceutical Bulletin, Planta Medica and BMC Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.